Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
|
US |
|
D
|
Dover Corp
F:DOV
|
US |
|
M
|
Mattel Inc
DUS:MTT
|
US |
|
F
|
Fresenius SE & Co KGaA
OTC:FSNUY
|
DE |
|
Kirin Holdings Co Ltd
F:KIR
|
JP |
|
COSCO Shipping Holdings Co Ltd
OTC:CICOF
|
CN |
|
U
|
United Parcel Service Inc
SWB:UPAB
|
US |
|
A
|
AXA SA
SWB:AXA
|
FR |
|
D
|
DR Horton Inc
DUS:HO2
|
US |
Wall St Price Targets
KALV Price Targets Summary
Kalvista Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
KALV is 30.47 USD with a low forecast of 27.27 USD and a high forecast of 37.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KALV's stock price target?
Price Target
30.47
USD
According to Wall Street analysts, the average 1-year price target for
KALV is 30.47 USD with a low forecast of 27.27 USD and a high forecast of 37.8 USD.
What is the Revenue forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
107%
Over the last 12 years, the compound annual growth rate for Revenue has been 49%. The projected CAGR for the next 3 years is 107%.
What is the Gross Profit forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
109%
The compound annual growth rate for Gross Profit over the next 3 years is 109%.